Vascular Closure Device (VCD) Market Size, Share & Trends Analysis | Global | 2024-2030 | MedCore | Includes: Invasive & Non-Invasive VCD Markets

  • Year: 2024
  • Scope: 10 Years
  • Region: Global
  • Published Date: 2023/11/06
  • Type: MedCore

Product Description

Overall, the global vascular closure device (VCD) market was valued at $863 million in 2023. This is expected to increase over the forecast period at a CAGR of 3.1% to reach over $1 billion.

Throughout this medical market research, we analyzed over 15 VCD companies across 7 continents and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, and to create accurate forecasts. The full report suite on the global market for VCDs extends its projections up to the year 2030, thereby providing a comprehensive and anticipatory understanding of the market trends and trajectories for the given period.

DATA TYPES INCLUDED

  • Unit SalesAverage Selling PricesMarket Value & Growth Trends
  • Forecasts Until 2030, and Historical Data to 2020
  • Market Drivers & Limiters for Each Segment
  • Competitive Analysis with Market Shares for Each Segment
  • Recent Mergers & Acquisitions
  • COVID19 Impact
  • Disease Overviews and Demographic Information
  • Company Profiles, Product Portfolios and SWOT for Top Competitors

Global VCD Market Insights

global VCD market

A current trend in the VCD market is the move towards faster and less invasive closure methods. There is an increasing preference for devices enabling swift hemostasis, less patient discomfort, and quicker recovery. Manufacturers are emphasizing the creation of closure devices that reduce the reliance on manual pressure or sutures, aiming for enhanced patient experiences and potentially lowering complication risks. Technological advancements have led to devices offering improved control and accuracy during closure, contributing to the broader adoption of VCDs in various interventional procedures.

Global VCD Market Share Insights

global VCD market

  • Abbott, the leading competitor, provides three invasive closure devices – StarClose™, PerClose ProGlide™, and ProStar™ XL. PerClose™ utilizes needles and a knot for arterial hole suturing, while StarClose™ features a nitinol clip for external closure to prevent emboli. ProStar™ XL is a suture-based device designed for closures at access sites between 8.5 F and 10 F.
  • Terumo‘s strong position in the VCD market is driven by the success of the Angio-Seal™ product line. The Angio-Seal™ VIP, an enhanced version with features like a coated suture and collagen sponge, has contributed significantly. The Angio-Seal™ Evolution™, introduced in 2010, includes an automated deployment system to address procedural variables.
  • Cardinal Health strengthened its VCD market presence with the 2015 Cordis acquisition. AccessClosure’s Mynx™ VCD, addressing challenges like vessel malpositioning, became part of Cardinal Health’s portfolio. The Mynx™ product line, now under Cardinal Health, includes Mynx™ACE® and MynxGrip® VCDs.

Market Segmentation Summary

  • Invasive VCD Market
  • Non-Invasive VCD Market

Global Research Scope Summary

Report Attribute Details
Regions North America (Canada, United States)
Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela)
Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.)
Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine)
Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates)
Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam)
Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
Base Year 2023
Forecast 2024-2030
Historical Data 2020-2023
Quantitative Coverage Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
Qualitative Coverage COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
Data Sources Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.

CONTACT US FOR ADDITIONAL INFORMATION

For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.

 

FREE Sample Report

Vascular Closure Device Market
21.1 Executive Summary
21.1.1 Global Vascular Closure Device Market Overview
21.1.2 Competitive Analysis
21.1.3 Procedures Included
21.1.4 Markets Included
21.1.5 Regions Included
21.2 Introduction
21.3 Procedure Numbers
21.3.1 Total Vascular Closure Device Procedures
21.3.2 Invasive VCD Procedures
21.3.3 Non-Invasive VCD Procedures
21.4 Market Overview
21.4.1 By Segment
21.4.2 By Region
21.5 Market Analysis and Forecast
21.5.1 Total Vascular Closure Device Market
21.5.2 Invasive VCD Market
21.5.2.1 Small-Bore Invasive VCD Market
21.5.2.2 Large-Bore Invasive VCD Market
21.5.3 Non-Invasive VCD Market
21.6 Drivers and Limiters
21.6.1 Market Drivers
21.6.2 Market Limiters
21.7 Competitive Market Share Analysis
Abbott Vascular
Terumo
Cardinal Health
Teleflex
Cardiva
Marine Polymer Technologies
Others
Chart 21‑1: Vascular Closure Device Market, Global, 2023 & 2030
Chart 21‑2: Vascular Closure Device Procedures, Global, 2023
Chart 21‑3: Vascular Closure Device Procedures by Region, Global, 2020 – 2030
Chart 21‑4: Vascular Closure Device Market by Segment, Global, 2020 – 2030
Chart 21‑5: Vascular Closure Device Market by Region, Global, 2020 – 2030
Chart 21‑6: Leading Competitors, Vascular Closure Device Market, Global, 2023
Figure 21‑1: Vascular Closure Device Procedures Covered
Figure 21‑2: Vascular Closure Device Markets Covered
Figure 21‑3: Vascular Closure Device Regions Covered, Global (1 of 2)
Figure 21‑4: Vascular Closure Device Regions Covered, Global (2 of 2)
Figure 21‑5: Vascular Closure Device Procedures by Segment, Global, 2020 – 2030
Figure 21‑6: Vascular Closure Device Procedures by Region, Global, 2020 – 2030
Figure 21‑7: Vascular Closure Device Procedures by Country, North America, 2020 – 2030
Figure 21‑8: Vascular Closure Device Procedures by Country, Latin America, 2020 – 2030 (1 of 2)
Figure 21‑9: Vascular Closure Device Procedures by Country, Latin America, 2020 – 2030 (2 of 2)
Figure 21‑10: Vascular Closure Device Procedures by Country, Western Europe, 2020 – 2030
Figure 21‑11: Vascular Closure Device Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2)
Figure 21‑12: Vascular Closure Device Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2)
Figure 21‑13: Vascular Closure Device Procedures by Country, Middle East, 2020 – 2030
Figure 21‑14: Vascular Closure Device Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3)
Figure 21‑15: Vascular Closure Device Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3)
Figure 21‑16: Vascular Closure Device Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3)
Figure 21‑17: Vascular Closure Device Procedures by Country, Africa, 2020 – 2030
Figure 21‑18: Invasive VCD Procedures by Region, Global, 2020 – 2030
Figure 21‑19: Invasive VCD Procedures by Country, North America, 2020 – 2030
Figure 21‑20: Invasive VCD Procedures by Country, Latin America, 2020 – 2030 (1 of 2)
Figure 21‑21: Invasive VCD Procedures by Country, Latin America, 2020 – 2030 (2 of 2)
Figure 21‑22: Invasive VCD Procedures by Country, Western Europe, 2020 – 2030
Figure 21‑23: Invasive VCD Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2)
Figure 21‑24: Invasive VCD Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2)
Figure 21‑25: Invasive VCD Procedures by Country, Middle East, 2020 – 2030
Figure 21‑26: Invasive VCD Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3)
Figure 21‑27: Invasive VCD Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3)
Figure 21‑28: Invasive VCD Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3)
Figure 21‑29: Invasive VCD Procedures by Country, Africa, 2020 – 2030
Figure 21‑30: Non-Invasive VCD Procedures by Region, Global, 2020 – 2030
Figure 21‑31: Non-Invasive VCD Procedures by Country, North America, 2020 – 2030
Figure 21‑32: Non-Invasive VCD Procedures by Country, Latin America, 2020 – 2030 (1 of 2)
Figure 21‑33: Non-Invasive VCD Procedures by Country, Latin America, 2020 – 2030 (2 of 2)
Figure 21‑34: Non-Invasive VCD Procedures by Country, Western Europe, 2020 – 2030
Figure 21‑35: Non-Invasive VCD Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2)
Figure 21‑36: Non-Invasive VCD Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2)
Figure 21‑37: Non-Invasive VCD Procedures by Country, Middle East, 2020 – 2030
Figure 21‑38: Non-Invasive VCD Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3)
Figure 21‑39: Non-Invasive VCD Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3)
Figure 21‑40: Non-Invasive VCD Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3)
Figure 21‑41: Non-Invasive VCD Procedures by Country, Africa, 2020 – 2030
Figure 21‑42: Vascular Closure Device Market by Segment, Global, 2020 – 2030 (US$M)
Figure 21‑43: Vascular Closure Device Market by Region, Global, 2020 – 2030 (US$M)
Figure 21‑44: Vascular Closure Device Market, Global, 2020 – 2030
Figure 21‑45: Units Sold by Region, Vascular Closure Device Market, Global, 2020 – 2030
Figure 21‑46: Average Selling Price by Region, Vascular Closure Device Market, Global, 2020 – 2030 (US$)
Figure 21‑47: Market Value by Region, Vascular Closure Device Market, Global, 2020 – 2030 (US$M)
Figure 21‑48: Invasive VCD Market by Segment, Global, 2020 – 2030 (US$M)
Figure 21‑49: Total Invasive VCD Market, Global, 2020 – 2030
Figure 21‑50: Units Sold by Region, Invasive VCD Market, Global, 2020 – 2030
Figure 21‑51: Average Selling Price by Region, Invasive VCD Market, Global, 2020 – 2030 (US$)
Figure 21‑52: Market Value by Region, Invasive VCD Market, Global, 2020 – 2030 (US$M)
Figure 21‑53: Small-Bore Invasive VCD Market, Global, 2020 – 2030
Figure 21‑54: Units Sold by Region, Small-Bore Invasive VCD Market, Global, 2020 – 2030
Figure 21‑55: Average Selling Price by Region, Small-Bore Invasive VCD Market, Global, 2020 – 2030 (US$)
Figure 21‑56: Market Value by Region, Small-Bore Invasive VCD Market, Global, 2020 – 2030 (US$M)
Figure 21‑57: Large-Bore Invasive VCD Market, Global, 2020 – 2030
Figure 21‑58: Units Sold by Region, Large-Bore Invasive VCD Market, Global, 2020 – 2030
Figure 21‑59: Average Selling Price by Region, Large-Bore Invasive VCD Market, Global, 2020 – 2030 (US$)
Figure 21‑60: Market Value by Region, Large-Bore Invasive VCD Market, Global, 2020 – 2030 (US$M)
Figure 21‑61: Non-Invasive VCD Market, Global, 2020 – 2030
Figure 21‑62: Units Sold by Region, Non-Invasive VCD Market, Global, 2020 – 2030
Figure 21‑63: Average Selling Price by Region, Non-Invasive VCD Market, Global, 2020 – 2030 (US$)
Figure 21‑64: Market Value by Region, Non-Invasive VCD Market, Global, 2020 – 2030 (US$M)
Figure 21‑65: Leading Competitors, Vascular Closure Device Market, Global, 2023

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Explore Options

Report Summary

FREE

Select License Type

Overall, the global vascular closure device (VCD) market was valued at $863 million in 2023. This is expected to increase over the forecast period at a CAGR of 3.1% to reach over $1 billion.

  • 2024
  • 10 Years
  • Global
  • 2023/11/06
  • MedCore
SKU: iDATA_GLPV24_MC_VCD Category:
0
    0
    Your Cart
    Your cart is emptyReturn to Report Library